Assessment of Some Bone Matrix Biochemical Parameters in Iraqi Postmenopausal Women with Osteoporosis

Abstract

Objectives: Osteoporosis (OP) is a systemic skeletal disorder characterized with bone mass loss and microstructure, resulting in fragility fractures. Continued secretion of Osteopontin (OPN), osteonectin (ON), osteocalcin (OCN), Parathyroid hormone (PTH) and Ca⁺² lead to bone remodeling disorders, followed by bone loss and osteoporosis (OP). The current study aims to investigate the biochemical proteins OPN, OCN, and ON in postmenopausal women with osteoporosis and determine whether we could use them as good indicators for OP diagnostics. Materials and Methods: Case- control study carried out between December 2022 and July 2023. OP disease was confirmed among 108 Iraqi postmenopausal women randomly selected from different Iraqi hospitals, Baghdad, Iraq. Their ages ranged between 45 and 70 years. According to DEXA scan results 70 samples were OP +ve results, while 40 samples were -ve (healthy control). Blood samples collected from all participants in order to assess the levels of Ca⁺², PTH, OPN, OCN, and ON by employing the ELISA technique. Results: High significant increase (P≤0.01) detected in PTH, OPN, and OCN serum levels, whereas, a significant decrease in Ca⁺² and ON, in OP patients as a comparison to control group. Conclusion: OPN, OCN, and ON measurements are accessible, inexpensive, and easy to use and could be considered a good indicators for OP diagnostics; beside to a DEXA scan as a sensitive monitoring indicator for early detection of osteoporosis.